CVM
Price:
$6.29
Market Cap:
$43.22M
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV...[Read more]
Industry
Biotechnology
IPO Date
1983-12-08
Stock Exchange
AMEX
Ticker
CVM
According to CEL-SCI Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 51.39M. This represents a change of 19.43% compared to the average of 43.03M of the last 4 quarters.
The mean historical Enterprise Value of CEL-SCI Corporation over the last ten years is 190.37M. The current 51.39M Enterprise Value has changed 2.60% with respect to the historical average. Over the past ten years (40 quarters), CVM's Enterprise Value was at its highest in in the March 2021 quarter at 737.76M. The Enterprise Value was at its lowest in in the September 2018 quarter at 3.07M.
Average
190.37M
Median
79.46M
Minimum
5.97M
Maximum
560.84M
Discovering the peaks and valleys of CEL-SCI Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.11%
Maximum Annual Enterprise Value = 560.84M
Minimum Annual Increase = -79.75%
Minimum Annual Enterprise Value = 5.97M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 82.77M | 8.70% |
| 2023 | 76.15M | -50.11% |
| 2022 | 152.63M | -70.43% |
| 2021 | 516.16M | -7.97% |
| 2020 | 560.84M | 51.36% |
| 2019 | 370.54M | 6.11% |
| 2018 | 5.97M | -51.72% |
| 2017 | 12.36M | -79.75% |
| 2016 | 61.06M | -6.38% |
| 2015 | 65.21M | -3.98% |
The current Enterprise Value of CEL-SCI Corporation (CVM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
103.85M
5-year avg
277.71M
10-year avg
190.37M
CEL-SCI Corporation’s Enterprise Value is greater than INmune Bio, Inc. (23.33M), greater than Barinthus Biotherapeutics plc (-33263316.00), less than Mersana Therapeutics, Inc. (83.22M), greater than Aligos Therapeutics, Inc. (26.21M), greater than Kezar Life Sciences, Inc. (20.85M), greater than OnKure Therapeutics, Inc. (-34012234.00), greater than Tempest Therapeutics, Inc. (9.57M), greater than X4 Pharmaceuticals, Inc. (6.31M), less than FibroGen, Inc. (103.14M), greater than PDS Biotechnology Corporation (-26077209422.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 23.33M | $49.98M | |
| -33263316.00 | $29.44M | |
| 83.22M | $137.32M | |
| 26.21M | $62.09M | |
| 20.85M | $45.77M | |
| -34012234.00 | $35.63M | |
| 9.57M | $15.19M | |
| 6.31M | $43.35M | |
| 103.14M | $33.37M | |
| -26077209422.00 | $43.78M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CEL-SCI Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CEL-SCI Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is CEL-SCI Corporation's Enterprise Value?
What is the highest Enterprise Value for CEL-SCI Corporation (CVM)?
What is the 3-year average Enterprise Value for CEL-SCI Corporation (CVM)?
What is the 5-year average Enterprise Value for CEL-SCI Corporation (CVM)?
How does the current Enterprise Value for CEL-SCI Corporation (CVM) compare to its historical average?